Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13503162 | 0.82 | ALDH1A1 (0.31) | TSHRALDH1A1 | |
| SCHEMBL3851447 | 0.78 | TSHR (0.32) | TSHR | |
| SCHEMBL22999495 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL16326627 | 0.73 | — | — | |
| SCHEMBL21928554 | 0.71 | — | — | |
| SCHEMBL13503166 | 0.70 | — | — | |
| SCHEMBL2985516 | 0.70 | — | — | |
| SCHEMBL25453522 | 0.70 | TSHR (0.35) | TSHRALDH1A1 | |
| Diallylsulfone SCHEMBL28152493 | 0.67 | TSHR (0.32) | TSHR | |
| SCHEMBL18480131 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171361-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-11145904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20200119400-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2020-04-16 | — | — | US | disclosed |
| US-10424794-B2 | Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method | CENTRAL GLASS CO., LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-07-20 | — | — | US | disclosed |
| EP-3165528-A1 | IONIC COMPLEX, ELECTROLYTE FOR NONAQUEOUS ELECTROLYTE BATTERY, NONAQUEOUS ELECTROLYTE BATTERY AND IONIC COMPLEX SYNTHESIS METHOD | Central Glass Co., Ltd. (JP) | 2017-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | ANO1, KCNN2, KCNN1 | TSHR 4226/4885ALDH1A1 518/4885 |
| US-20200119400-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | KCNN1, KCNN2, ANO1 | TSHR 2324/4885ALDH1A1 607/4885 |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | HCN2, KCNN4, KCNH3 | TSHR 3190/4885ALDH1A1 3265/4885 |
| US-10424794-B2 | Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method | HCN2, KCNN4, KCNH3 | TSHR 3190/4885ALDH1A1 3265/4885 |
| US-11171361-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | KCNN1, KCNN2, ANO1 | TSHR 2324/4885ALDH1A1 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.